The Pandol Lab in the Cedars-Sinai Pancreatic Research Program is concentrating efforts to better understand the molecular mechanisms of pancreatic diseases and develop new prevention, diagnostic and effective treatments for these diseases. The Pancreatic Research Program's multidisciplinary team consists of molecular biologists, cell biologists, computational chemists, population scientists, clinical scientists and physicians, all working toward the common goal of enhanced treatments and outcomes for pancreatic cancer, pancreatitis and diabetes patients. Our research is focused on the following:
- Early diagnosis and disease prevention
- Signaling mechanisms, underlying risk factors and disease pathophysiology
- Development of novel therapeutics and enhanced treatments
- Human testing of new treatments
- Microscopy and Cell Culture
- Chemistry and Biochemistry
- Animal Physiology and Human Biomedical Sample Preparation
- Molecular Biology and Physical Biochemistry
- Specialized Reagents
- Access to Other Specialized Expertise and Equipment
- Computation and Structural Modeling
- Professional Societies
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Pandol Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Gukovskaya AS, Pandol SJ, Gukovsky I.
Curr Opin Gastroenterol. 2016 Jul 13.
Pham H, Hui H, Morvaridi S, Cai J, Zhang S, Tan J, Wu V, Levin N, Knudsen B, Goddard WA 3rd, Pandol SJ, Abrol R.
Biochem Biophys Res Commun. 2016 Jul 1;475(3):295-300.
Setiawan VW, Pandol SJ, Porcel J, Wilkens LR, Le Marchand L, Pike MC, Monroe KR.
Pancreas. 2016 Jul;45(6):819-825.